Addus HomeCare (NASDAQ:ADUS) Receives New Coverage from Analysts at KeyCorp

KeyCorp began coverage on shares of Addus HomeCare (NASDAQ:ADUS) in a research report released on Friday, Marketbeat.com reports. The brokerage issued an overweight rating and a $150.00 target price on the stock.

Several other analysts also recently issued reports on ADUS. TD Cowen upped their price objective on Addus HomeCare from $128.00 to $137.00 and gave the company a buy rating in a research report on Thursday, August 8th. Stephens restated an overweight rating and issued a $138.00 price objective on shares of Addus HomeCare in a research report on Tuesday, August 6th. Oppenheimer upped their price objective on Addus HomeCare from $140.00 to $145.00 and gave the company an outperform rating in a research report on Monday, September 23rd. Royal Bank of Canada restated an outperform rating and issued a $141.00 price objective on shares of Addus HomeCare in a research report on Tuesday, September 3rd. Finally, StockNews.com downgraded Addus HomeCare from a strong-buy rating to a buy rating in a research report on Sunday, July 7th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of Moderate Buy and an average target price of $131.38.

Addus HomeCare Price Performance

Shares of ADUS stock opened at $131.81 on Friday. The business’s fifty day moving average price is $129.83 and its 200 day moving average price is $117.54. Addus HomeCare has a 1-year low of $78.35 and a 1-year high of $136.12. The firm has a market capitalization of $2.39 billion, a PE ratio of 32.71, a P/E/G ratio of 2.33 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings data on Monday, August 5th. The company reported $1.35 earnings per share for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. The firm had revenue of $286.90 million for the quarter, compared to analyst estimates of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. Addus HomeCare’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.94 earnings per share. Equities research analysts expect that Addus HomeCare will post 4.58 earnings per share for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Addus HomeCare news, Director Esteban Lopez sold 500 shares of the company’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the sale, the director now owns 3,366 shares in the company, valued at $429,165. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now owns 7,215 shares in the company, valued at $961,687.35. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 22,917 shares of company stock valued at $3,050,082. Company insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

Several institutional investors and hedge funds have recently bought and sold shares of ADUS. Creative Planning grew its holdings in shares of Addus HomeCare by 5.8% during the third quarter. Creative Planning now owns 4,910 shares of the company’s stock valued at $653,000 after purchasing an additional 267 shares during the last quarter. Oliver Luxxe Assets LLC grew its holdings in Addus HomeCare by 244.8% in the 3rd quarter. Oliver Luxxe Assets LLC now owns 16,512 shares of the company’s stock worth $2,197,000 after buying an additional 11,723 shares in the last quarter. Redhawk Wealth Advisors Inc. bought a new position in Addus HomeCare in the 3rd quarter worth approximately $922,000. Inspire Investing LLC grew its holdings in Addus HomeCare by 3.3% in the 3rd quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after buying an additional 100 shares in the last quarter. Finally, GAMMA Investing LLC grew its holdings in Addus HomeCare by 25.7% in the 3rd quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock worth $124,000 after buying an additional 191 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.